KALA BIO, Inc.
KALA
Rang in Aktien
#30748
Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the... Kala Bio, Inc. functions as a biopharmaceutical company dedicated to the creation and commercialization of new therapeutic solutions. The core of their strategy involves utilizing proprietary nanoparticle technology, specifically mucus penetrating particles (MPPs). Initially, their focus for these treatments is directed towards ophthalmic diseases. The company was established in 2009 by co-founders Justin Hanes, Robert S. Langer, and Colin R. Gardner, and its headquarters are located in Arlington, Massachusetts.
Aktienkurs
$0.75
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$14.50M
Veränderung (1 Tag)
2.78%
Veränderung (1 Jahr)
-98.28%
Land
US
Handel KALA BIO, Inc. (KALA)
Kategorie
Healthcare
Kursverlauf für KALA BIO, Inc. (KALA)
Höchster Schlusskurs: $0.28 am 2026-10-01
Niedrigster Schlusskurs: $37.46K am 2018-01-01
Niedrigster Schlusskurs: $37.46K am 2018-01-01
Kursverlauf der Aktie von KALA BIO, Inc. von 2018 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | -63.88% |
| 2025 | -88.09% |
| 2024 | -12.41% |
| 2023 | -37.21% |
| 2022 | -84.21% |
| 2021 | -79.90% |
| 2020 | 49.13% |
| 2019 | 15.30% |
| 2018 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
